This series of scientific webinars is intended to provide methodology and knowledge related to clinical research.
IDDI has organized more than 25 scientific webinars so far.
All the recordings of our scientific webinars are available on:
If you want to have access to the presentation of those webinars, please fill out the form in the section On-Demand Webinars.
Assessing Treatment Benefit in Immuno-Oncology
September 25, 2018
Free Live Webinar: Assessing Treatment Benefit in Immuno-Oncology In this webinar we reviewed key issues related to endpoints in immuno-oncology, with a brief overview of the four different sets of criteria for response assessment in immunotherapy. Then we reviewed the […]
Biostatistical Challenges of Trials in Rare Diseases
April 26, 2018
Free Webinar on Biostatistical Challenges of Trials in Rare Diseases VIEW RECORDED WEBINAR CONTENTS: In this webinar: We will start by briefly reviewing the European and international initiatives on rare diseases. We will describe special statistical designs and analysis methodologies to address the […]
A New Statistical Method: Generalized Pairwise Comparisons
February 22, 2018
A New Statistical Method: Generalized Pairwise Comparisons to Assess Treatment Benefit/Risk IN THIS WEBINAR OUR SPEAKERS DESCRIBED A NEW STATISTICAL METHOD, NAMED ‘GENERALIZED PAIRWISE COMPARISONS (GPC)’ FOR THE ASSESSMENT OF TREATMENT BENEFIT/RISK. VIEW THE RECORDED WEBINAR HERE Erratum to the recording: Please […]
Treatment Allocation in Randomized Trials: Challenges and Best Practices
October 19, 2017
In this free webinar on Treatment Allocation in Randomized Trials, the speakers discussed: the rationale for the various randomization methods, with illustration from real clinical trials and some considerations about the performance characteristics of the different methods. logistic issues related […]
Tumor-Size-Based Measurements as Endpoint in Cancer Clinical Trials
June 15, 2017
Since the early days of clinical cancer research, given the expected direct cytotoxicity of chemotherapy, tumor shrinkage has been used as a proxy for anticancer activity. IDDI organized a webinar on the use of endpoints based on tumor measurements in cancer […]